Feasibility of photofrin II as a radiosensitizing agent in solid tumors--preliminary results.

Photofrin II has been demonstrated to serve as a specific and selective radiosensitizing agent in in vitro and in vivo tumor models. We aimed to investigate the feasibility of a clinical applicatio